BeStock  
Markets › Compare › AUPH vs PVLA

AUPH vs PVLA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
AUPH · Aurinia Pharmaceuticals$14.70 ▼ 1.28%
PVLA · Palvella Therapeutics$142.85 ▼ 2.00%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

72100129157186Nov 24, '25May 26, '26Nov 20, '26
  • AUPH -8.8%
  • PVLA +45.7%

Head to head

MetricAUPHPVLA
Price$14.70$142.85
Change today▼ 1.28%▼ 2.00%
Market cap$1.97B$2.09B
Return, 3 months-11.3%-2.0%
Return, year to date-7.8%+36.5%
Return, 1 year-6.3%+51.8%
P/E (TTM)6.4–
P/B3.010.6
P/E percentile vs own 5y67th27th
Dividend yield––
Revenue growth (YoY, latest qtr)+13.9%–
Net profit growth (YoY)+0.5%-117.2%
Gross margin90.6%–
Operating margin48.6%–
Net margin97.7%–
Return on equity61.4%-63.4%
Analyst target vs. price+29.3%+59.4%
Analyst buy share67%100%
RSI (14)3046
30-day volatility31.7%70.1%
Max drawdown, 1 year-21.8%-31.1%
Trend readStrong downtrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • PVLA is the largest of the group by market value.
  • PVLA has returned the most over the past year.
  • AUPH has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top